KANSAS CITY, Kan., July 29, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...
Cingulate's stock surges over 159% after being granted a European patent for its lead ADHD treatment asset, CTx-1301. CTx-1301 is designed to deliver three timed releases of medication throughout the ...
Herpes Simplex Encephalitis: Flair axial MRIs. Note the abnormal (bright) signal in both temporal lobes (left image). Also note the involvement of the insula on the right side (middle image) and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback